Raul R. Rodriguez - Jun 9, 2022 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Role
CEO, President, Director
Signature
/s/ Dolly Vance (Attorney-in-Fact)
Stock symbol
RIGL
Transactions as of
Jun 9, 2022
Transactions value $
$688,400
Form type
4
Date filed
6/13/2022, 04:36 PM
Previous filing
Jan 26, 2022
Next filing
Sep 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RIGL Common Stock Purchase $688K +1M +255.25% $0.69 1.39M Jun 9, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions ranging from $0.67 to $0.70. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each such separate price.